• Popular
    • Medicine
    • Radiology
    • Cardiology
    • Surgery
    • Nanomedicine
    • Military Medicine
    • Rehab
  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS
  • Submit PR
  • Log in
Medgadget
Medgadget
  • Popular
    • Medicine
      Antibacterial Peptide Spray Safe for Use on Wounds

      Antibacterial Peptide Spray Safe for Use on Wounds

      Flexible Sensors Detect Heavy Metals in Sweat

      Flexible Sensors Detect Heavy Metals in Sweat

      Nanopore Sensor to Study Protein Aggregation in Neurodegeneration

      Nanopore Sensor to Study Protein Aggregation in Neurodegeneration

      Biobots Use Optogenetic Muscle Actuators for Movement

      Biobots Use Optogenetic Muscle Actuators for Movement

    • Radiology
      Tiny Patch for Cardiac Ultrasound Imaging

      Tiny Patch for Cardiac Ultrasound Imaging

      Ultrasound Tornado Rapidly Disrupts Blood Clots

      Ultrasound Tornado Rapidly Disrupts Blood Clots

      Exciting Medtech at the Healthcareᐩ Expo Taiwan

      Exciting Medtech at the Healthcareᐩ Expo Taiwan

      Fluorescence Imaging System Illuminates Tumor Depth

      Fluorescence Imaging System Illuminates Tumor Depth

    • Cardiology
      Tiny Patch for Cardiac Ultrasound Imaging

      Tiny Patch for Cardiac Ultrasound Imaging

      Belt Monitors Heart Failure Patients

      Belt Monitors Heart Failure Patients

      Camera Measures Blood Pressure with Quick Look

      Camera Measures Blood Pressure with Quick Look

      Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

      Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

    • Surgery
      Antibacterial Peptide Spray Safe for Use on Wounds

      Antibacterial Peptide Spray Safe for Use on Wounds

      Microneedle Bandage for Hemostatic Control

      Microneedle Bandage for Hemostatic Control

      Biobots Use Optogenetic Muscle Actuators for Movement

      Biobots Use Optogenetic Muscle Actuators for Movement

      Implantable Device Adheres to Muscle, Treats Atrophy

      Implantable Device Adheres to Muscle, Treats Atrophy

    • Nanomedicine
      Extra Hot Nanoparticles for Cancer Therapy

      Extra Hot Nanoparticles for Cancer Therapy

      Making Tumors Tastier for the Immune System

      Making Tumors Tastier for the Immune System

      Improved Membrane Coating for Anti-Cancer Nanoparticles

      Improved Membrane Coating for Anti-Cancer Nanoparticles

      Magnetic Bacteria Target Tumors

      Magnetic Bacteria Target Tumors

    • Military Medicine
      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fabric Makes Electricity from Movement to Power Wearables

      Fabric Makes Electricity from Movement to Power Wearables

      Wearable Uses Microneedles to Track Metabolism

      Wearable Uses Microneedles to Track Metabolism

    • Rehab
      Smart Walking Stick for Visually Impaired People

      Smart Walking Stick for Visually Impaired People

      Implantable Device Adheres to Muscle, Treats Atrophy

      Implantable Device Adheres to Muscle, Treats Atrophy

      Non-Invasive Spinal Modulation for Cerebral Palsy

      Non-Invasive Spinal Modulation for Cerebral Palsy

      Implanted Magnets for Prosthetic Control

      Implanted Magnets for Prosthetic Control

  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Log in
  • Submit PR
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS

Basal Cell Nevus Syndrome Drug Market 2019 Top Key Players are Adgero Biopharmaceuticals, Transgene, Galderma, Mayne Pharma, PellePharm and Forecast to 2025

July 31st, 2019 BrandEssence Market Research Company Pvt Ltd Releases

Basal Cell Nevus Syndrome Drug Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2019-2025– Increasing cases of skin cancer is the key factor driving the growth of Global Basal Cell Nevus Syndrome Drug Market.

Basal Cell Nevus Syndrome Drug Market is valued at USD XX Million in 2018 and expected to reach USD XX Million by 2025 with the CAGR of XX% over the forecast period.

Basal cell nevus syndrome (BCNS), also called as nevoid basal cell carcinoma syndrome and Gorlin syndrome, is a rare autosomal dominant disorder that can be divided into developmental anomalies and postnatal tumors, especially basal cell carcinomas (BCCs) and skin cancer. The prevalence of BCNS is variously estimated to be 1 in 60,000 and 1 in 120,000 persons. The syndrome affects both sexes and occurs in a wide variety of cultural groups, and therefore does not have a predilection for a particular skin type. Erivedge or Vismodegib is a capsule or drug that is used for the treatment of basal cell carcinoma (BCC) if a customer does not want to go through surgery and radiation. The consent of vismodegib on January 30, 2012, represents the first Hedgehog signaling pathway targeting agent to gain U.S. Food and Drug Administration (FDA) approval. Basal cell cancer is linked with mutations in the “Hedgehog” pathway. Hedgehog controls cell growth in embryos, and generally it is not active in adult tissue cells. Hedgehog mutations with basal cell cancer can activate the closed pathway resulting in uncontrolled growth of skin basal cells. Vismodegib works in interfering the proteins involved in activating the Hedgehog signal. Other than Vismodegib, drugs like Itraconazole, Patidegib Hydrochloride, REM-001 are also used to cure Basal cell nevus syndrome.

Get Sample Copy of This Premium Report @ https://brandessenceresearch.biz/Request/Sample?ResearchPostId=71672&RequestType=Sample

The basal cell nevus syndrome drug market is segmented on the basis of product type, application and region. Based on product type, the basal cell nevus syndrome drug market is segmented into Itraconazole, Patidegib Hydrochloride, REM-001, TG-1042, Trifarotene, Vismodegib and others. On the basis of application, the basal cell nevus syndrome drug market is segmented into clinic, hospital and others.

The regions covered in this Basal Cell Nevus Syndrome Drug Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of basal cell nevus syndrome drug is sub divided into U.S., Mexico, Canada, UK, France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

Key Players for Global Basal Cell Nevus Syndrome Drug Market Report–

Major Players of Basal Cell Nevus Syndrome Drug Software market are Adgero Biopharmaceuticals Holdings Inc, Transgene SA, Galderma SA, Mayne Pharma Group Ltd, PellePharm Inc and others.

Increasing Cases of Skin Cancer is the Key Factor Driving the Growth of Global Basal Cell Nevus Syndrome Drug Market.

Basal cell carcinoma (BCC) is the most common cancer in individuals with fair skin type and steadily increasing in incidence and it is a rarely occurring skin cancer. In skin cancer diagnosis, BCC is being recognized in more numbers, which accounts for 80% of non-melanoma skin cancer. Standard treatment is; complete surgical removal and radiation therapy is an option for inoperable tumors or those where the post-operative defect would be cosmetically disfiguring or functionally disabling. For this reason,in recent years new therapeutic approaches have been developed both for locally advanced or metastatic disease (systemic medications) as well as for superficial BCC which is the use of drugs like vismodegib and others. Due to its fewer side effects many customers are preferring to undergo drugs treatment rather than any other methods as it is directly affecting the growth of cancer affected cells which may hamper the market growth.

Request for Methodology @ https://brandessenceresearch.biz/Request/Sample?ResearchPostId=71672&RequestType=Methodology

North America is Expected to Dominate the Global Basal Cell Nevus Syndrome Drug Market

The global basal cell nevus syndrome drug market is segmented into North America, Europe, Asia-Pacific and Middle East & Africa. North America is expeceted to capture the highest share of basal cell nevus syndrome drug market due to the growing cases of basal cell carcinoma (BCC) among white people as it is common in non-melanoma skin type. It accounts for 80% of non-melanoma skin cancer and is increasingly seen in younger patients. Recently published metanalysis showed the demography of annual incidence rates/100,000 population which is 115 BCC in Great Britain, 70–80 BCC in Germany, Switzerland and Italy, 170 BCC in the USA and >800 BCC in Australia. In turn these countries are in demand of Basal Cell Nevus Syndrome Drug which supplements the growth of this market. Europe has second highest market share and Asia pacific region in this market and is estimated to grow with moderate CAGR.

Key Benefits for Global Basal Cell Nevus Syndrome Drug Market Report–

  • Global market report covers in depth historical and forecast analysis.
  • Global market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
  • Global market report helps to identify opportunities in market place.
  • Global market report covers extensive analysis of emerging trends and competitive landscape.

Get Full information of This Report @ https://brandessenceresearch.biz/Lifesciences-and-Healthcare/Basal-Cell-Nevus-Syndrome-Drug-Market-Share/Summary

Global Basal Cell Nevus Syndrome Drug Market Segmentation: –

BY Product Type:

  • Itraconazole,
  • Patidegib Hydrochloride,
  • REM-001,
  • TG-1042,
  • Trifarotene,
  • Vismodegib
  • Others

By Application:

  • Clinic
  • Hospital
  • Others

By Regional & Country Analysis:

  • North America
    • US.
    • Canada
  • Europe
    • UK.
    • France
    • Germany
    • Italy
  • Asia Pacific
    • China
    • Japan
    • India
    • Southeast Asia
  • Latin America
    • Brazil
    • Mexico
  • Middle East and Africa
    • Africa
    • Rest of Middle East and Africa

About us:Brandessence Market Research and Consulting Pvt. ltd.

Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.

Contact us at: +44-2038074155 or mail us at alan@brandessenceresearch.biz

Website: https://brandessenceresearch.biz

Related Report:

Medical Devices Industry Reports 2019

3D Printing in Healthcare Market Global Size, Trends, Competitive, Historical & Forecast Analysis, 2019-2025

Long Term Care Market Global Size, Trends, Competitive, Historical & Forecast Analysis, 2019-2025

Microcarrier Market Global Size, Trends, Competitive, Historical & Forecast Analysis, 2019-2025

 

Sign up and submit a press release

Sponsored
C-mo Medical Solutions extends seed investment round to €4.8 million to transform cough monitoring

C-mo Medical Solutions extends seed investment round to €4.8 million to transform cough monitoring

New Clarius Power Fan HD3 Delivers a First for Handheld Ultrasound: Continuous Scanning

New Clarius Power Fan HD3 Delivers a First for Handheld Ultrasound: Continuous Scanning

Fluidx Unveils New Embolic for Neurovascular Use

Fluidx Unveils New Embolic for Neurovascular Use

Annalise.ai and Nuance Communications (a Microsoft Company) Announce Key Partnership to Improve Patient Outcomes with Workflow-Integrated AI

Annalise.ai and Nuance Communications (a Microsoft Company) Announce Key Partnership to Improve Patient Outcomes with Workflow-Integrated AI

PT Genie Unveils New Brand Identity Reflecting Company’s Transformation and Focus on the Global Future of AI and Machine Learning in Digital Healthcare

interviews & reviews
Balance Boards to Stay Active in the Offfice: Interview with Joel Heath, CEO of FluidStance 

Balance Boards to Stay Active in the Offfice: Interview with Joel Heath, CEO of FluidStance 

Exciting Medtech at the Healthcareᐩ Expo Taiwan

Exciting Medtech at the Healthcareᐩ Expo Taiwan

Medgadget Visits Healthcareᐩ Expo Taiwan

Medgadget Visits Healthcareᐩ Expo Taiwan

Diabetes Management Tech for Type II patients: Interview with Jeffrey Brewer, CEO of Bigfoot Biomedical

Diabetes Management Tech for Type II patients: Interview with Jeffrey Brewer, CEO of Bigfoot Biomedical

Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

In-Office Pediatric Ear Tube Procedures: Interview with Preceptis Medical's Greg Mielke

In-Office Pediatric Ear Tube Procedures: Interview with Preceptis Medical's Greg Mielke

Symani Microsurgical Robotic System: Interview with Mark Toland, CEO of Medical Microinstruments

Symani Microsurgical Robotic System: Interview with Mark Toland, CEO of Medical Microinstruments

  • Subscribe
  • Contact us
  • Submit
  • About
  • Back to top
Medgadget

Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004.

  • About
  • Editorial policies
  • Contact
  • Terms of Service
  • Privacy
  • Submit press release
  • Advertise
© Medgadget, Inc. All rights reserved. | The Medical Revolution Will Be Blogged.
Please support this website by adding us to your whitelist in your ad blocker. Ads are what helps us bring you premium content! Thank you!
Posting....
  • Facebook
  • Twitter
  • LinkedIn
  • Reddit
  • Email